Physician profile
Gail S Gerber
NPI 1144227521
$1,238.76
in general payments reported to CMS, 2019-2025
16 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $59.21 · 2021: $99.03 · 2022: $233 · 2023: $128 · 2024: $264 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.09 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $241.35 | 2019-2025 | |
| Astellas Pharma US INC | $158.54 | 2022-2025 | Veozah |
| Therapeuticsmd, INC. | $133.02 | 2019-2022 | |
| Abbvie INC. | $101.59 | 2019-2022 | |
| Amgen INC. | $90.63 | 2019-2024 | Evenity, Prolia |
| Duchesnay USA Incorporated | $81.39 | 2019 | |
| Millicent US INC | $81.29 | 2024-2025 | Femring, Intrarosa |
| Mayne Pharma Commercial LLC | $77.03 | 2023-2025 | |
| Exeltis, USA INC. | $55.60 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $53.32 | 2022-2024 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $40.52 | 2022-2024 | Gardasil, Gardasil 9 |
| Avion Pharmaceuticals | $39.52 | 2022 | |
| Organon LLC | $32.14 | 2021-2024 | |
| Hologic Sales and Service, LLC | $22.13 | 2024 | Myosure Tissue Removal Device |
| Convatec INC. | $19.52 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.